DelveInsight's Biologics Drug Substance Manufacturing Market Insights report provides the current and forecast market ...

The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic diseases, which is driving the need for biologics development ...

With 17 years' experience, Mabion offers an “end-to-end” solution, covering all stages of biologic drug development, from early clone selection and small-scale manufacturing through process ...

The entire development process, from generating a hybridoma ... The current clinical pipeline of biologic drugs includes 240 mAbs and 120 proteins in various other categories, including ...

The sorting, structuring, and analysis of biological data are increasingly ... and uncertainty within the drug development process, increasing costs. Fortunately, blockchain technology may provide ...

The Cryo-Electron Microscope (cryo-EM) market has witnessed significant advancements in recent years, driven by the increasing demand for high-resolution imaging techniques across various industries.

Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart ...

Dr. N.K. Prasanna, Editor of IJBB, played a pivotal role in coordinating the editorial process, while Dr. Charu Verma, Head ...

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company") is pleased to announce the formation of a U.S.-based ...

Under the agreement, the companies will advance development of IBI3009, Innovent’s ADC candidate, which has received IND approvals in the US, China, and Australia.

On the 5th, LG AI Research signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu, ...

The pharmaceutical industry has experienced a substantial revolution with the introduction of novel technologies as well as ...